- Home
- ALCE vs CSCI Comparison
ALCE vs CSCI Comparison
Compare ALCE & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALCE
- CSCI
- Stock Information
- Founded
- ALCE 2019
- CSCI 1990
- Country
- ALCE United States
- CSCI Canada
- Employees
- ALCE N/A
- CSCI N/A
- Industry
- ALCE Power Generation
- CSCI
- Sector
- ALCE Utilities
- CSCI
- Exchange
- ALCE Nasdaq
- CSCI NYSE
- Market Cap
- ALCE 3.7M
- CSCI 11.1M
- IPO Year
- ALCE N/A
- CSCI 1996
- Fundamental
- Price
- ALCE $0.84
- CSCI $2.50
- Analyst Decision
- ALCE
- CSCI
- Analyst Count
- ALCE 0
- CSCI 0
- Target Price
- ALCE N/A
- CSCI N/A
- AVG Volume (30 Days)
- ALCE 99.3K
- CSCI 4.1K
- Earning Date
- ALCE 11-19-2024
- CSCI 11-12-2024
- Dividend Yield
- ALCE N/A
- CSCI N/A
- EPS Growth
- ALCE N/A
- CSCI N/A
- EPS
- ALCE N/A
- CSCI N/A
- Revenue
- ALCE N/A
- CSCI $4,834,000.00
- Revenue This Year
- ALCE N/A
- CSCI N/A
- Revenue Next Year
- ALCE N/A
- CSCI N/A
- P/E Ratio
- ALCE N/A
- CSCI N/A
- Revenue Growth
- ALCE N/A
- CSCI N/A
- 52 Week Low
- ALCE $0.74
- CSCI $2.50
- 52 Week High
- ALCE $140.75
- CSCI $11.10
- Technical
- Relative Strength Index (RSI)
- ALCE 28.33
- CSCI N/A
- Support Level
- ALCE $0.75
- CSCI N/A
- Resistance Level
- ALCE $0.84
- CSCI N/A
- Average True Range (ATR)
- ALCE 0.11
- CSCI 0.00
- MACD
- ALCE 0.03
- CSCI 0.00
- Stochastic Oscillator
- ALCE 19.04
- CSCI 0.00
About ALCE Alternus Clean Energy Inc.
Alternus Clean Energy Inc is an international independent clean energy producer. It develops, installs, owns and operates a diverse portfolio of utility-scale solar photovoltaic power stations (PV parks) in Europe and the USA as a long-term owner. The solar parks benefit from long-term government offtake contracts and/or Power Purchase Agreements (PPAs) with investment grade off-takers, plus energy sales to local power grids. It has approximately 8 operating parks, a total of 44 MWp in operation.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.